Live feed16:05:00·59dPRReleaseMangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government StudyMGRX· Mangoceuticals Inc.Health CareOriginal source
